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AntidiabeticAbstract Phytochemical investigation of the antidiabetic chloroform fraction of the ethanolic
extract obtained from the aerial parts of Callistemon lanceolatus DC led to the isolation of three
new phytoconstituents, one ﬂavone, 8-(100-hydroxyisopranyl)-5,6-dihydroxy-7,40-dimethoxy ﬂavone
(1) and two phenolic esters, 2,3,4-trihydroxyphenethyl tetracontanoate (2) and 2,3,4-trihydroxy-
phenethyl tetracontanoate-4-b-xylopyranoside (3). The isolated compound 1 exhibited signiﬁcant
in vivo blood glucose lowering effect comparable to the standard drugs Pioglitazone and Rosiglit-
azone in streptozotocin induced diabetic rats without causing any toxic effect on the pancreas and
liver. Compound 1 showed a glide score of 7.89 against PPAR-c target in molecular docking stud-
ies which is signiﬁcantly higher than the glide score of reference molecule Rosiglitazone (glide score
of 5.77). Compound 1 also exhibited moderate in vitro PPAR-c transactivation activity of 48.52%
in comparison with standard drugs rosiglitazone and pioglitazone, which showed a transactivation
activity of 80.47% and 65.27%, respectively.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The genus Callistemon belongs to family Myrtaceae and com-
prises over 30 species. These are woody aromatic trees or
shrubs and widely distributed all over the world
(Anonymous, 1992). The plant is used for ornamental pur-
poses, and has applications in folk medicine as antidiabeticidiabetic
2 S. Nazreen et al.(Nazreen et al., 2011), antimicrobial, antiinﬂammatory, anti-
staphylococcal, and antithrombin (Kobayashi et al., 2006;
Gomber and Saxena, 2007; Saxena and Gomber, 2006;
Chistokhodova et al., 2002). It is also used for nematicidal, lar-
vicidal and pupicidal effects (Sangwan et al., 1990). Previous
phytochemical studies on different parts of Callistemon lance-
olatus (commonly known as Red bottlebrush) have led to the
isolation of C-methyl ﬂavonoids, triterpenoids, tannins and
phloroglucinol derivatives (Wrigley and Fagg, 1993; Huq
and Misra, 1997; Wollenweber et al., 2000; Younes, 1975).
In our earlier studies we have reported the isolation of two
new antidiabetic ﬂavones from the chloroform fraction of
the ethanolic extract of this plant (Nazreen et al., 2012). In
continuation to our earlier studies, we report herein the pres-
ence of a new ﬂavone and two new phenolic esters from the
chloroform fraction of the ethanolic extract of this plant.
These isolated compounds have been evaluated for in vivo anti-
diabetic potential, molecular docking study and in vitro Perox-
isome Proliferator Activated Receptor (PPAR-c)
transactivation activity.
2. Experimental
2.1. General
Melting points were determined on Veego VMP-III and were
uncorrected. UV spectra were measured on DV 20 Spectroscan
spectrophotometer. IR spectra were recorded on Bruker spec-
trometer using KBr disc. 1H NMR, 13C NMR and 2D NMR
were recorded on a Bruker AM-400 (400 MHz) spectrometer
with TMS as the internal standard and chemical shifts are
reported in parts per million relative to CDCl3 (7.27 ppm for
1H and 77.23 for 13C). Mass spectra were recorded on a Jeol
JMS-D 300 instrument ﬁtted with a JMS 2000 data system
at 70 eV using Argon/Xenon as the FAB gas. All solvents were
of analytical grade (Merck). Thin Layer Chromatography
(TLC) was performed on precoated plates (Silica gel 60 F254,
Merck) and Silica gel (60–120 mesh, Merck) was used for col-
umn chromatography. Pioglitazone and Rosiglitazone were
procured from Ranbaxy Laboratories, Gurgaon with purity
97.4%.
2.2. Plant material
The aerial parts of C. lanceolatus DC were collected from
Saket Nursery, New Delhi in March 2010 and authenticated
by Dr. H. B. Singh, Taxonomist, National Institute of Science
Communication and Information resources, New Delhi. A
voucher specimen (No. 1386/188) has been deposited in the
author’s laboratory.
2.3. Extraction and Isolation
The air dried and powdered aerial parts of C. lanceolatus DC
(5 kg) were extracted with 95% ethanol in a Soxhlet apparatus.
The ethanolic extract was concentrated under reduced pressure
to yield a brown viscous mass (550 g). The ethanolic extract
was fractionated with petroleum ether (3 · 1.0 L), CHCl3
(3 · 1.0 L), and MeOH (3 · 1.0 L) to furnish petroleum ether
fraction (200 g), CHCl3 fraction (150 g) and MeOH fractionPlease cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
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at room temperature (25–30 C). The chloroform fraction
was column chromatographed (CC) over silica gel (60–120
mesh, 1000 g) and eluted with petroleum ether–CHCl3 gradi-
ent system from 100:0 to 0:100 to give two crude fractions
(1–2). Fraction 1 (50 g) obtained from petroleum ether–CHCl3
(4:6) was further CC over silica gel (60–120 mesh) eluting with
same solvent to afford compound 1 which was puriﬁed by crys-
tallization with CHCl3–MeOH (80 mg; Rf: 0.34; petroleum
ether–CHCl3, 9.5:0.5). Fraction 2 (65 g) obtained from petro-
leum ether–CHCl3 (3:7) was subjected to CC over silica gel
(60–120 mesh) to yield two sub fractions (2a–2b). Fraction
2a when recolumned over silica gel (60–120 mesh) and eluted
with same solvent, followed by crystallization in CHCl3–
MeOH yielded compound 2 (102 mg; Rf: 0.83; n-hexane–
EtOAc, 3.5:1.5). Fraction 2b was further CC and recrystallized
to yield 3 (90 mg; Rf: 0.42; n-hexane–EtOAc, 3.5:1.5).
2.3.1. Compound 1
Yellow crystals; m.p. 135–136 C; UV (MeOH) kmax: 286,
323 nm; IR (KBr) tmax (cm
1): 3432 (OH), 1670 (C‚O),
1075 (CAO); 1H and 13C NMR (CDCl3): see Table 1; FAB
MS (positive): m/z 400 [M]+ (calcd 400.42 for C22H24O7),
313 [M-C5H11O]
+, 166 [181-Me]+, 117 [132-Me]+.
2.3.2. Compound 2
Silver colored crystals; m.p. 79–80 C; UV (MeOH) kmax:
278 nm; IR (KBr) tmax (cm
1): 3460 (OH), 1729 (C‚O),
1178 (CAO); 1H and 13C NMR (CDCl3): see Table 2; FAB
MS (positive): m/z 744 [M]+ (calcd 744.66 for C48H88O5).
2.3.3. Compound 3
Orange ﬂakes; m.p. 88–89 C; UV (MeOH) kmax: 264 nm; IR
(KBr) tmax (cm
1): 3437 (OH), 1722 (C‚O), 1015 (CAO);
1H and 13C NMR (CDCl3): see Table 2; FAB MS (positive):
m/z 876 [M]+ (calcd 876.66 for C53H96O9).
2.3.3.1. Acid hydrolysis of 3. Compound 3 was reﬂuxed with
2 N HCl in 80% MeOH for one hour. After cooling, the reac-
tion mixture was poured into crushed ice, and the hydrolysate
was then extracted with EtOAc to give the aglycone, com-
pound 2. The sugar in the concentrated water-soluble portion
was compared with standard sugars on a TLC plate with n-
BuOH–EtOAc–iso-PrOH–AcOH–H2O (7:20:12:7:6). The
sugar was identiﬁed as xylose, Rf = 0.47.
2.4. Antidiabetic activity
The antidiabetic activity was performed in streptozotocin
(STZ) induced diabetic rats as per the previously reported
method (Nazreen et al., 2011).
2.4.1. Experimental protocol
The rats were divided into seven groups comprising of ﬁve ani-
mals each.
Group I: Control rats receiving 0.1 M citrate buffer (pH
4.5).
Group II: Diabetic controls receiving STZ (60 mg/kg b.w.)
intraperitoneally.rs from Callistemon lanceolatus DC: Their molecular docking and antidiabetic
014.11.029
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molar to standard drug Pioglitazone) in aqueous solution
orally.
Group IV: Diabetic rats given compound 2 (75.23 mg, equi-
molar to standard drug Pioglitazone) in aqueous solution
orally.
Group V: Diabetic rats given compound 3 (88.58 mg, equi-
molar to standard drug Pioglitazone) in aqueous solution
orally.
Group VI: Diabetic rats given standard drug pioglitazone
(36 mg/kg b.w.) in aqueous solution orally.
Group VII: Diabetic rats given standard drug rosiglitazone
(36 mg/kg b.w.) in aqueous solution orally.
The compounds (1–3) were administered a single dose on
the 1st day and the blood glucose level was measured on the
1st, 7th and 15th day of the experiment as per standard proto-
cols by glucose oxidase method (Dahlqvist, 1961).
At the end of the experimental period, the rats were anaes-
thetized and sacriﬁced by cervical dislocation. Organs (pan-
creas and liver) were removed for histopathological evaluation.
2.5. Molecular docking study
Molecular docking studies involve mainly protein selection &
preparation, grid generation, ligand preparation, docking &
further analysis of docking studies. Schrodinger Software
was mainly used for all the above steps. Protein with Accession
number 3CS8 was selected and downloaded from Protein Data
Bank, and is reported to bind with the drug Rosiglitazone. The
protein was imported, optimized, minimized while removing
unwanted molecules and other defects reported by the soft-
ware. Molecules drawn in 3D form were reﬁned by LigPrep
module. The molecules were subjected to OPLS-2005 force
ﬁeld to generate single low energy 3-D structure. Docking
study was done using Extra precision and Write XP descriptor
information. This generates favourable ligand poses which are
further screened through ﬁlters to examine spatial ﬁt of the
ligand in the active site. Ligand poses which pass through ini-
tial screening are subjected to evaluation and minimization of
grid approximation. Scoring is then done on energy minimized
poses to generate glide score.
2.6. PPAR-c transactivation assay
Human embryonic kidney (HEK) 293 cells were cultured in
DMEM with 10% heat inactivated foetal bovine serum in a
humidiﬁed 5% CO2 atmosphere at 37 C. Cells were seeded
in 6-well plates the day before transfection to give a conﬂu-
ence of 70–80% at transfection. Cells grown in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM) were inoculated in 96-
well plate containing 60,000 cells/well. Cells were transfected
with 2.5 lL of Peroxisome Proliferator Response Element-
Luciferase (PPRE-Luc), 6.67 lL of PPAR-c, 1.0 lL of Renil-
la and 20 lL of Lipofectamine. Following 5 h after transfec-
tion, cells were treated with compound (10 lM) for 24 h and
then collected with Cell Culture Lysis buffer. Luciferase
activity was monitored on luminometer (Perkinelmer, USA)
using the luciferase kit (Promega) according to the manufac-
turer’s instructions. Rosiglitazone and Pioglitazone were used
as standards.Please cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
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Data was analysed by GraphPad Instat 3.1 software by one
way ANOVA followed by Dunnett’s ‘t’ test (n= 5),
*p< 0.05, **p< 0.01 signiﬁcant from diabetic control.
3. Results and discussion
3.1. Structure elucidation
Compound 1 was isolated as yellow crystals and gave positive
Shinoda test for ﬂavonoids. Its UV absorption maxima at 286
and 323 nm were typical of substituted ﬂavones (Boue et al.,
2003). The +ve FAB mass spectrum exhibited a molecular
ion peak at m/z 400 consistent with the molecular formula of
a ﬂavone, C22H24O7. The other prominent ion peaks appeared
at m/z 313 [M-C5H11O]
+, 181 [C8H5O5]
+, 166 [C8H5O5-Me]
+,
132 [C9H8O]
+, 117 [C9H8O-Me]
+ supporting the existence of
two methoxy moiety in the molecule. The IR spectrum
revealed absorption bands at 3432 cm1 (OH), 1670 cm1
(C‚O) and 1075 cm1 (CAO) functionalities. The 1H NMR
spectrum showed the presence of four aromatic protons (ring
B) at dH 7.83 (d, J= 8.2 Hz, H-20, H-60) and dH 7.02 (d,
J= 8.8 Hz, H-30, H-50) and two methoxy groups at dH 3.92
(6H, s) forming an AA0XX0 system. The presence of two aro-
matic OH groups at dH 12.91 (s, 5-OH) and dH 9.92 (s, 6-OH)
and a oleﬁnic proton at dH 6.57 (s, H-3) indicated 5,6-dihy-
droxylated pattern for ring A of ﬂavone skeleton. The presence
of a-hydroxy-c,c-dimethylpropyl group was supported by pro-
ton signals at dH 3.85 (1H, t, J= 7.2 Hz, H-100), dH 2.21 (1H,
m, H-300), dH 1.25 (2H, brs, H-200), dH 6.48 (1H, s, 100-OH), dH
0.88 (3H, d, J= 8.8 Hz, H-400) and dH 0.81 (3H, d, J= 8.4 Hz,
H-500) and carbon signals at dC 89.33, 31.94, 29.71, 8.57, 7.29
respectively in the 13C NMR spectrum. The 1H-1H COSY
spectrum of 1 showed correlations of H-100 (dH 3.85) with
H2-2
00 (dH 1.25) and H-300(dH 2.21); H-400 (dH 0.88) with H-
300(dH 2.21), H3-500(dH 0.81) and H2-200 (dH 1.25) and H-2’ (dH
7.83) with H-3’ (dH 7.02) and H-6’ (dH 7.83); H-3’ (dH 7.02)
with H-2’ (dH 7.83) and H-5’ (dH 7.02). The long-range
1H–13C correlations (HMBC) of H-3 (d 6.57) with C-2 (d
163.60), C-10 (d 123.75), C-4 (d 182.40), C-10 (d 105.32) indi-
cated that there is a proton at C-3. The presence of two hydro-
xyl groups at C-5 and C-6 is based on the long range 1H–13C
correlations which showed correlations of 5-OH (d 12.91) with
C-5 (d 162.38), C-6 (d 155.93), C-10 (d 105.32) while 6-OH (d
9.92) revealed correlations with C-6 (d 155.93), C-5 (d 162.38),
C-7 (d 163.86). The attachment of two methoxy groups at C-7
and C-40 is evident from the long range correlations observed
between d 3.92 (7-OMe) with C-7 (d 163.86), C-6 (d 155.93),
C-8 (d 123.87) and d 3.92 (40-OMe) with C-40 (d 162.60). By
analogy, the side chain at C-8 could be deduced from the
long-range 1H–13C correlations between H-100 (d 3.85) with
C-8 (d 123.87), C-9 (d 158.76), C-7 (163.86); H-200 (d 1.25) with
C-8 (d 123.87), C-400 (d 8.57), C-500 (d 7.29) (Fig. 1). Thus, the
compound 1 was identiﬁed as 8-(100-hydroxyisopranyl)-5,6-
dihydroxy-7,4’-dimethoxy ﬂavone.
Compound 2 isolated as white shiny crystals exhibited a
molecular ion peak at m/z 744 (calcd 744.66) in its +ve
FAB MS, calculated for the molecular formula C48H88O5. It
showed UV absorption maxima (MeOH) at 278 nm, and char-
acteristic IR absorption bands at 3460, 1729 and 1178 cm1 forrs from Callistemon lanceolatus DC: Their molecular docking and antidiabetic
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Figure 1 COSY, HSQC and HMBC correlations of compounds 1–3.
4 S. Nazreen et al.hydroxy, carbonyl and ether functionalities, respectively. The
1H NMR spectrum of 2 showed the presence of only two aro-
matic protons at d 7.07 (1H, d, J= 8.4 Hz, H-6) and d 6.76
(1H, d, J= 8.4 Hz, H-5) indicating the aromatic ring is tetra-
substituted. The signals of a long alkyl side chain appeared at d
2.85 (2H, t, J= 7.2 Hz, H2-7), 4.23 (2H, t, J= 7.2 Hz, H2-8),
2.27 (2H, t, J= 7.6 Hz, H2-2
0), 1.60 (74 H, brs, 37 · CH2) for
methylene protons. A three proton signal appeared at d 0.88
(3H, t, J= 6.3 Hz, Me-400) for terminal methyl protons. This
data was supported by 13C NMR spectrum which exhibited
signals at d 34.38 (C-7), d 64.97 (C-8), 34.29 (C-20), d 31.94–
22.71 (37 · CH2) and d 14.41 (Me-400). The 13C NMR spec-
trum also revealed downﬁeld signals at d 173.97 for carbonyl
carbon (C-10), d 156.21, 156.05 & 154.26 for three oxygenated
aromatic carbons (C-4, C-3, C-2) and d 129.99 (C-6) & 115.33
(C-5) for unsubstituted aromatic carbons. Assignment of each
substituent in the aromatic ring was determined by HSQC and
HMBC correlations (Fig. 1). From the HSQC spectrum, the
aromatic protons H-6 (d 7.07) showed correlation with C-6
(d 129.99), H-5 (d 6.76) with C-5 (115.33), benzylic protons
H2-7 (d 2.85) with C-7 (d 34.38), oxygenated methylenePlease cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
activities. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2protons H2-8 (d 4.23) with C-8 (d 64.97), methylene protons
H2-2
0 (d 2.27) with C-20 (d 34.29), remaining seventy four meth-
ylene protons (d 1.60) with C-30 to C-370 (d 31.94–22.71) and
terminal methyl protons H3-40
0 (d 0.88) with C-400 (d 14.41).
The presence of three hydroxyl groups at C-2, C-3 and C-4
was determined from the long-range 1H–13C correlations
(HMBC) which showed interactions of 2-OH (d 9.42) with
C-2 (d 154.26), C-3 (d 156.05), C-1 (d 130.05); 3-OH (d
10.82) with C-3 (d 156.05), C-2 (d 154.26), C-4 (d 156.21); 4-
OH (d 11.58) with C-4 (d 156.21), C-3 (d 156.05), C-5 (d
115.33). The protons H2-7 (d 2.85) exhibited HMBC correla-
tions with C-1 (d 130.05), C-2 (d 154.26), C-6 (d 129.99), C-8
(d 64.97); H2-8 (d 4.23) with C-7 (d 34.38), C-1 (d 130.05),
C-10 (d 173.97); H2-20 (d 2.27) with C-10 (d 173.97), C-30 to
C-370 (d 31.94–22.71). Thus, the compound was characterized
as 2,3,4-trihydroxyphenethyl tetracontanoate.
Compound 3 was isolated as orange ﬂakes and gave the
molecular formula C53H96O9 by +ve FAB MS [M]
+ at m/z
876 (calcd 877.32), which was supported by its IR and NMR
data. It showed UV absorption maxima (MeOH) at 264 nm,
and IR absorption bands at 3437, 1722 and 1015 cm1 forrs from Callistemon lanceolatus DC: Their molecular docking and antidiabetic
014.11.029
Figure 2 Effect of compounds 1–3 on blood glucose lowering in streptozotocin induced diabetic rats. Data is analysed by one way
ANOVA followed by Dunnett’s ‘t’ test and expressed as mean ± SEM from ﬁve observations; ** indicates p< 0.01 vs diabetic control.
Figure 3A Histopathology report of rat pancreas. STZ treated groups showing reduce islet of Langerhans. Compound 1 and
pioglitazone treated groups showing recovery of islet of Langerhans.
Figure 3B Histopathology report of rat liver showing normal arrangement of hepatocytes in the centrizonal area (Control). Compound
1 and pioglitazone treated groups showing normal arrangement of cells in the liver lobule and normal arrangement of hepatocytes in the
centrizonal area. Strepto (STZ) treated groups showing perivenular inﬂammatory inﬁltration ﬁlling over the sinusoidal vacuolation of the
hepatocyte nuclei.
New ﬂavone and phenolic esters from Callistemon lanceolatus DC 5hydroxy, carbonyl and ether functionalities, respectively. The
signals in 1H NMR and 13C NMR spectra were similar to com-
pound 2 except that it showed additional signals for a sugar
moiety. The 1H NMR revealed the characteristic anomeric sig-
nal (H-100) as a doublet at dH 5.37 (J= 8.7 Hz). The H-200
appeared as double doublet at d 3.80 (J= 5.3, 6.1 Hz). The
H-300, H-400 and H-500 were observed as multiplets at d 3.62,
3.35 and 3.92, respectively. The 13C NMR of 3 were similar
to compound 2 except that it exhibited ﬁve additional signals
of the sugar unit at dC 108.11, 73.90, 79.94, 71.69 and 67.67Please cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
activities. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.20which were assigned to C-100, C-200, C-300, C-400 and C-500,
respectively (Aydogmus et al., 2006). Acid hydrolysis of 3
yielded an aglycone compound 2 and xylose sugar. The agly-
cone moiety was conﬁrmed from mass spectrum showing frag-
ment ion peak at m/z 744 for the molecular formula C48H87O5.
The position of glycosidation was conﬁrmed by HMBC
spectrum which showed a long range correlation of anomeric
proton H-100 (d 5.37, J= 8.7 Hz) with C-4 (156.61) (Fig. 1).
Based on these evidences, compound 3 was characterized as
2,3,4-trihydroxyphenethyl tetracontanoate-4-b-xylopyranoside.rs from Callistemon lanceolatus DC: Their molecular docking and antidiabetic
14.11.029
Table 1 1H (400 MHz, d ppm) and 13C NMR data (100 MHz,
d ppm) of compound 1.
Positions dH, J (Hz) dC
2 – 163.60
3 6.57 (1H, s) 104.05
4 – 182.40
5 12.91 (1H, s, –OH) 162.38
6 9.92 (1H, s, –OH) 155.93
7 – 163.86
8 – 123.87
9 – 158.76
10 – 105.32
10 – 123.75
20&60 7.83 (2H, d, J= 8.2 Hz) 127.99, 127.95
30&50 7.02 (2H, d, J= 8.8 Hz) 114.56, 114.46
40 – 162.60
100 3.85 (1H, t, J= 7.2 Hz) 89.33
200 1.25 (2H, brs) 29.71
300 2.21 (1H, m) 31.94
400 0.88 (3H, d, J= 8.8 Hz) 8.57
500 0.81 (3H, d, J= 8.4 Hz) 7.29
100-OH 6.48 (1H,s) –
40-OMe & 7-OMe 3.92 (6H, s) 55.90, 55.52
6 S. Nazreen et al.3.2. Biological activity
The isolated compounds 1–3 were tested for in vivo antidia-
betic activity in streptozotocin induced diabetic rats. Com-
pound 1 signiﬁcantly lowered blood glucose level toTable 3 Docking score of compound 1.
Ligands G-score Glide energy
1 7.89 38.38
Rosiglitazone 5.77 71.55
Table 2 1H (400 MHz, d ppm) and 13C NMR data (100 MHz, d p
Positions 2
dH, J (Hz) dC CDCl3
1 – 130.05
2 9.42 (1H, s, –OH) 154.26
3 10.82 (1H, s, –OH) 156.05
4 11.58 (1H, s, OH) 156.21
5 6.76 (1H, d, J= 8.4 Hz) 115.33
6 7.07 (1H, d, J= 8.4 Hz) 129.99
7 2.85 (2H, t, J= 7.2 Hz) 34.38
8 4.23 (2H, t, J= 7.2 Hz) 64.97
10 – 173.97
20 2.27 (2H, t, J= 7.6 Hz) 34.29
30 1.60 (74 H, brs, 37 · CH2) 31.94–22.71 (37 · CH
Me 0.88 (3H, t, J= 6.3 Hz, Me-400) 14.41
100 – –
200 – –
300 – –
400 – –
500 – –
Please cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
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drugs pioglitazone (132 ± 5.02) and rosiglitazone
(144 ± 6.3) after 15 days of study (Fig. 2). Compound 2 and
3 lowered blood glucose level to 202 mg/dl ± 9.72 and
203 mg/dl ± 9.92, respectively. The histopathological exami-
nation of the pancreas and liver of STZ-induced diabetic rats
revealed extensive alterations. STZ caused signiﬁcant damage
to islets of langerhans of the pancreas showing markedly
reduced islet cells, which were restored to near normal upon
treatment with compound 1 and pioglitazone (Fig. 3). The
liver of diabetic rats showed perivenular inﬂammatory inﬁltra-
tion ﬁlling over the sinusoidal vacuolation of the hepatocyte
nuclei. The pathological changes observed in STZ-induced dia-
betes appeared closer to the normal after treatment with com-
pound 1 and pioglitazone. It was observed that the compound
1 has the protective effect on the liver as well as the pancreas of
the diabetic rats.
In order to validate the results of in vivo antidiabetic activ-
ity, the active compound 1 was docked for in silico studies
against PPAR-c target. PPAR-c receptor has been found to
be an important drug target for regulating fatty acid storage
and glucose metabolism. On activation by ligands, this recep-
tor leads to an increased insulin sensitivity and further glucose
uptake. Molecular docking studies were done to provide
insights of binding modes of molecules inside the large pocket
of PPAR-c receptors. It was observed that compound 1
showed glide core of -7.89 which is signiﬁcantly higher than
the glide score of standard drug Rosiglitazone (glide score of
5.77). Compound 1 was found to show p–p interaction with
LYS 261 residue of the protein and is deeply buried into
hydrophobic pocket of PPAR-c receptor. The in silico ADMELogP O/W PSA LogS
3.313 102.13 5.785
3.475 94.37 4.497
pm) of compounds 2 and 3.
3
dH, J (Hz) dC, CDCl3
– 131.25
8.66 (1H, s, –OH) 154.76
10.50 (1H, s, –OH) 155.15
– 156.61
6.76 (1H, d, J= 8.1 Hz) 116.32
7.08 (1H, d, J= 8.1 Hz) 129.69
2.85 (2H, t, J= 6.9 Hz) 34.98
4.23 (2H, t, J= 7.1 Hz) 64.77
– 173.07
2.40 (2H, m) 34.19
2) 1.63 (74 H, brs, 37 · CH2) 31.74–22.61 (37 · CH2)
0.85 (3H, t, J= 6.1 Hz, Me-400) 14.41
5.37 (1H, d, J= 8.7 Hz) 108.11
3.80 (2H, dd, J= 5.3, 6.1 Hz) 73.90
3.62 (1H, m) 79.94
3.35 (1H, m) 71.69
3.92 (2H, m) 67.67
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Figure 4 Molecular docking of compound 1 showing interaction PPAR-c receptor.
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Figure 5 PPAR-c transactivation activity of compound 1.
Values are expressed as mean ± SEM from three experiments
conducted in triplicate at 10 lM.
New ﬂavone and phenolic esters from Callistemon lanceolatus DC 7(Absorption, Distribution, Metabolism and Excretion) predic-
tion of compound 1 was found to be within the acceptable
range. The calculated glide score, binding energies and pre-
dicted ADME of compound 1 are presented in Table 3 and
Fig. 4. In order to conﬁrm the mechanism of action the com-
pound 1 was evaluated for in vitro PPAR-c transactivation
activity. It was found to exhibit moderate in vitro PPAR-c
transactivation activity of 48.52% in comparison with the
standard drugs Rosiglitazone and Pioglitazone, which showed
80.47% and 65.27% transactivation activity, respectively
(Fig. 5).
4. Conclusion
In the present study, one new ﬂavone and two new phenolic
esters were isolated from C. lanceolatus and subjected to eval-
uation of their anti diabetic potential. Compound 1 exhibited
signiﬁcant in vivo blood glucose lowering effect in STZ induced
diabetic rats without causing any toxicity to the liver and pan-
creas. Compound 1 exhibited a glide score of 7.89 against
PPAR-c target in molecular docking studies which isPlease cite this article in press as: Nazreen, S. et al., New ﬂavone and phenolic este
activities. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.20signiﬁcantly higher than that of reference molecule rosiglitaz-
one (glide score of 5.77). It also exhibited moderate in vitro
PPAR-c transactivation activity of 48.52% in comparison with
the standard drugs Rosiglitazone and Pioglitazone, which
showed a transactivation activity of 80.47% and 65.27%
respectively. Compound 1 may have exerted the antidiabetic
effect by activating PPAR-c receptors.
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